Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M54.5Revenue (TTM) $M9.5Net Margin (%)-166.1Altman Z-Score-7.1
Enterprise Value $M44.6EPS (TTM) $-3.1Operating Margin %-158.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.2Pre-tax Margin (%)-166.1Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %--Quick Ratio3.6Cash flow > EarningsN
Price/Sales2.15-y EBITDA Growth Rate %16.9Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-202.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.1ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NBY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NBY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Najafi RaminCEO, 10% Owner 2015-08-20Buy480$11.75-68.94view
Pioneer Pharma (Singapore) Pte10% Owner 2015-03-03Buy103,600$15-75.67view
SIECZKAREK MARK MDirector 2015-03-03Buy6,667$15-75.67view
Najafi RaminChairman 2015-03-03Buy6,667$15-75.67view
Najafi RaminChairman 2014-12-12Buy2,000$16.25-77.54view
PAULSON THOMAS JCFO 2014-12-12Buy400$17-78.53view
Stroman David W.SVP, Ophthalmic Product Devt. 2014-12-12Buy400$16.5-77.88view
Najafi RaminChairman 2014-12-11Buy800$15-75.67view
PAULSON THOMAS JCFO 2014-12-09Buy400$16.75-78.21view
Najafi RaminChairman 2014-12-05Buy1,000$16.25-77.54view

Press Releases about NBY :

Quarterly/Annual Reports about NBY:

News about NBY:

Articles On GuruFocus.com
NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 

More From Other Websites
NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016 Jan 09 2017
NovaBay's Avenova Brings Quick Relief to Children Suffering from Eye Conditions, Writes Steven J.... Dec 19 2016
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Dec 19 2016
NovaBay to Present at LD Micro Main Event Dec 01 2016
MULTIMEDIA UPDATE - NovaBay's Avenova Is Breakthrough in Fight Against Contact Lens Intolerance Nov 29 2016
NovaBay's Avenova Is Breakthrough in Fight Against Contact Lens Intolerance Nov 29 2016
Five Stocks Under $5.00 for December (NAK, GGB) Nov 23 2016
NOVABAY PHARMACEUTICALS, INC. Financials Nov 18 2016
NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14,... Nov 14 2016
NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results Nov 10 2016
NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2016
NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results Nov 10 2016
NovaBay Pharmaceuticals to Hold Third Quarter 2016 Conference Call on November 10 Nov 04 2016
NovaBay Pharmaceuticals to Hold Third Quarter 2016 Conference Call on November 10 Nov 03 2016
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 31 2016
NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements Oct 31 2016
NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements Oct 31 2016
NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Oct 24 2016
Eyelid Hygiene Cleanser Called "Avenova(R) with Neutrox(R)" Offers Help for Tired, Aging Eyes Oct 11 2016
NovaBay Pharmaceuticals Receives $7 Million from Early Warrant Exercise Oct 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)